Clearpoint Neuro Inc (CLPT) — Cash Flow-to-Debt Ratio
Clearpoint Neuro Inc (CLPT) has a Cash Flow-to-Debt Ratio of -0.09x as of June 2026, meaning its operating cash flow of $-7.01 Million could theoretically repay 0% of its total liabilities ($75.97 Million) in one year. See Clearpoint Neuro Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clearpoint Neuro Inc Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Clearpoint Neuro Inc across 15 annual periods. For the full cash flow conversion analysis, see Clearpoint Neuro Inc operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Clearpoint Neuro Inc (2011–2025)
Year-by-year debt coverage analysis for Clearpoint Neuro Inc. Check CLPT operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.34x | $-23.93 Million | $69.73 Million | ▲ +47.1% |
| 2024 | -0.65x | $-8.95 Million | $13.80 Million | ▼ -1.6% |
| 2023 | -0.64x | $-13.72 Million | $21.49 Million | ▲ +26.5% |
| 2022 | -0.87x | $-16.17 Million | $18.60 Million | ▼ -14.9% |
| 2021 | -0.76x | $-12.70 Million | $16.79 Million | ▼ -162.8% |
| 2020 | -0.29x | $-7.81 Million | $27.14 Million | ▲ +25.9% |
| 2019 | -0.39x | $-2.85 Million | $7.34 Million | ▲ +46.8% |
| 2018 | -0.73x | $-4.63 Million | $6.35 Million | ▲ +1.7% |
| 2017 | -0.74x | $-5.99 Million | $8.07 Million | ▼ -4.1% |
| 2016 | -0.71x | $-5.82 Million | $8.16 Million | ▲ +0.2% |
| 2015 | -0.71x | $-8.64 Million | $12.08 Million | ▼ -33.0% |
| 2014 | -0.54x | $-7.25 Million | $13.49 Million | ▼ -1.7% |
| 2013 | -0.53x | $-7.78 Million | $14.71 Million | ▲ +19.7% |
| 2012 | -0.66x | $-7.43 Million | $11.29 Million | ▼ -162.5% |
| 2011 | -0.25x | $-6.24 Million | $24.87 Million | — |